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RESEARCH ARTICLE
Host-Microbe Biology

crossm
Monoclonal Antibodies to Intracellular Stages of
Cryptosporidium parvum Deﬁne Life Cycle Progression In Vitro
Georgia Wilke,a Soumya Ravindran,a Lisa Funkhouser-Jones,a Jennifer Barks,a Qiuling Wang,a Kelli L. VanDussen,b
Thaddeus S. Stappenbeck,b Theresa B. Kuhlenschmidt,c Mark S. Kuhlenschmidt,c L. David Sibleya
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA

b

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri,
USA

c

Department of Pathobiology, University of Illinois College of Veterinary Medicine, Urbana, Illinois, USA

Among the obstacles hindering Cryptosporidium research is the lack of
an in vitro culture system that supports complete life development and propagation.
This major barrier has led to a shortage of widely available anti-Cryptosporidium antibodies and a lack of markers for staging developmental progression. Previously developed antibodies against Cryptosporidium were raised against extracellular stages
or recombinant proteins, leading to antibodies with limited reactivity across the parasite life cycle. Here we sought to create antibodies that recognize novel epitopes
that could be used to deﬁne intracellular development. We identiﬁed a mouse epithelial cell line that supported C. parvum growth, enabling immunization of mice
with infected cells to create a bank of monoclonal antibodies (MAbs) against intracellular parasite stages while avoiding the development of host-speciﬁc antibodies.
From this bank, we identiﬁed 12 antibodies with a range of reactivities across the
parasite life cycle. Importantly, we identiﬁed speciﬁc MAbs that can distinguish different life cycle stages, such as trophozoites, merozoites, type I versus II meronts,
and macrogamonts. These MAbs provide valuable tools for the Cryptosporidium research community and will facilitate future investigation into parasite biology.

ABSTRACT

IMPORTANCE Cryptosporidium is a protozoan parasite that causes gastrointestinal
disease in humans and animals. Currently, there is a limited array of antibodies available against the parasite, which hinders imaging studies and makes it difﬁcult to visualize the parasite life cycle in different culture systems. In order to alleviate this reagent gap, we created a library of novel antibodies against the intracellular life cycle
stages of Cryptosporidium. We identiﬁed antibodies that recognize speciﬁc life cycle
stages in distinctive ways, enabling unambiguous description of the parasite life cycle. These MAbs will aid future investigation into Cryptosporidium biology and help
illuminate growth differences between various culture platforms.
KEYWORDS Cryptosporidium, cytoskeleton, intracellular parasites, membrane
proteins, monoclonal antibodies, sexual development
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C

ryptosporidium is a genus of protozoan parasites that causes diarrheal disease
(cryptosporidiosis) in humans and other animals. Over 20 species are recognized,
but the majority of human cases are caused by C. parvum or C. hominis (1). For decades,
Cryptosporidium was mainly recognized as a cause of chronic diarrhea in patients
immunocompromised from HIV/AIDS (2). However, an investigation into the etiologies
of diarrheal illnesses in children in Africa and south Asia found that Cryptosporidium is
second only to rotavirus as a cause of diarrhea in infants in these regions (3). Since
diarrheal disease is a signiﬁcant cause of child mortality (4), this discovery has led to
increased interest in cryptosporidiosis and a reexamination of the barriers to studying
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Cryptosporidium (5). The main obstacle hindering research on this parasite is that it
cannot be propagated in vitro and instead must be passaged through large animals
such as calves to generate infectious oocysts. C. parvum can also infect mice, although
susceptible mouse models are limited to immunodeﬁcient (6) or neonatal animals (7).
Current cell culture models rely on human adenocarcinoma cell lines (e.g., Caco-2 and
HCT-8) that do not support complete life cycle development (8). Without the ability to
propagate, clonal lines cannot be established and in vitro studies are restricted to
studying limited rounds of asexual replication and incomplete sexual development.
Genetic manipulation is possible if the parasites are passed through immunocompromised mice (9); however, it is not feasible to examine the cellular basis of complex
phenotypes without a parallel in vitro system for development.
Cryptosporidium has a complex life cycle consisting of both an asexual phase
(merogony) and a sexual phase (gametogony) that culminates in oocyst formation (10).
There are a limited number of antibodies that identify different life cycle stages of
Cryptosporidium, especially intracellular stages. In part, this limitation is due to the fact
that antibodies have typically been generated against extracellular stages such as
oocysts (11) and sporozoites (12), and many of these recognize widely conserved
epitopes found in intracellular stages (13). For example, it has been reported that
epitopes shared on gp60, a glycoprotein involved in parasite adhesion to host cells, and
its processed components of gp15 and gp45 are expressed on both sporozoites and
merozoites (14–16). Antibodies have also been made against speciﬁc proteins (15, 17,
18); however, this method of antibody production does not typically allow for the
discovery of novel antigens. Additionally, many antibodies previously raised against
Cryptosporidium were made in rabbits (15, 18, 19), which is a nonrenewable source of
antibody. Collectively, these available reagents do not allow the speciﬁc life cycle stages
to be clearly delineated with unique markers, confounding attempts to track development during in vitro growth.
Our goal was to create a mouse hybridoma bank against Cryptosporidium to provide
reagents to easily identify life stages, discover new antigens, and provide a renewable
reagent source. One barrier to making antibodies against intracellular stages of Cryptosporidium is that there is no mouse cell line that supports robust parasite growth (8).
Although human adenocarcinoma lines allow for limited intracellular growth, immunization with culture material derived from such heterologous sources would likely
generate many host-speciﬁc antibodies. Here, we tested primary murine ileal epithelial
cells (IECs) and found that C. parvum underwent efﬁcient ampliﬁcation in these cells.
The use of mouse IECs (mIECs) allowed us to immunize mice with infected cell lysates
without the risk of generating host-speciﬁc antibodies. Using this strategy, we created
a hybridoma bank expressing novel monoclonal antibodies (MAbs) against intracellular
parasite stages. By examining the timing of expression and patterns of staining, we
identiﬁed antibodies with distinctive reactivity against speciﬁc life cycle stages, such as
trophozoites, merozoites, type I and II meronts, and macrogamonts. Collectively, this
“antibody toolkit” should lead to a deeper understanding of parasite biology and foster
efforts to deﬁne conditions for complete development and propagation in vitro.
RESULTS AND DISCUSSION
Establishing a mouse hybridoma bank against C. parvum. We initially sought to
identify a mouse cell type that would support robust parasite growth in vitro. It has
been reported that bovine and human isolates of Cryptosporidium will grow in mouse
L929 ﬁbroblasts (20) and peritoneal macrophages (21), but these cell types are not
commonly infected in vivo. Instead, Cryptosporidium primarily grows in the epithelial
cells of the small intestine (22). Recent developments have shown that mouse intestinal
stem cells can be maintained in culture as spheroids using media containing a cocktail
of speciﬁc growth factors (23). When these stem cells are grown as monolayers on
Transwells, they develop into polarized epithelial monolayers that include enteroendocrine cells, Paneth cells, mucin-producing goblet cells, and enterocytes (24). As
shown previously, these different lineages are present in the monolayers at rates similar
May/June 2018 Volume 3 Issue 3 e00124-18
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FIG 1 Infecting primary mouse ileal epithelial cells (mIECs) and immunization of mice. (A) Mouse intestinal
stem cells were passaged as spheroids. To establish monolayers, spheroids were trypsinized and the cells
seeded onto Transwell membranes. (B) Twenty-four hours after plating the monolayer, the cells were
infected with oocysts and samples were harvested at intervals to isolate genomic DNA for estimation of
growth by qPCR. The data shown are from one experiment but are representative of the growth seen in
3 or more experiments. n ⫽ 3 Transwells at each time point. Values are means ⫾ standard deviation (SD).
(C) Five mice were immunized with infected mIEC lysates, obtained at 48 h postinfection, following a series
of 6 footpad injections over 2 weeks. Seventeen days after the initial injection, the mice were sacriﬁced and
the popliteal lymph nodes were isolated.

to what is found in the mouse intestine (24). Such monolayers could provide a much
more natural niche for growth of C. parvum than typical transformed cell lines.
Consequently, we tested primary mouse ileal epithelial cells (mIECs) that were differentiated from intestinal stem cells for their ability to support C. parvum growth in vitro.
C. parvum was able to achieve high levels of ampliﬁcation over a 3-day period in mIECs
grown in Transwells as shown by quantitative PCR (qPCR) (Fig. 1).
Having successfully identiﬁed a mouse cell line that supported robust development
of C. parvum, we immunized mice with infected mIEC lysates, performed a fusion, and
screened the resulting hybridomas by microscopy to identify novel antibodies to
C. parvum. Following sequential subcloning, individual monoclonal antibodies (MAbs)
were screened on infected mIECs and HCT-8 cells to investigate their reactivity against
different life cycle stages of C. parvum. To monitor C. parvum infection, we stained the
monolayers with a rabbit polyclonal antibody raised against the Toxoplasma gondii
strain RH that was broadly cross-reactive to C. parvum antigens based on Western
blotting (see Fig. S1 in the supplemental material). As shown in Fig. 2, this anti-RH
antibody (labeled “Cp” in ﬁgures) recognized both asexual and sexual stages of
C. parvum by immunoﬂuorescence (immunoﬂuorescent antibody assay [IFA]).
Starting from a total of 31 MAbs, we identiﬁed 12 antibodies with distinctive staining
patterns (Table 1). Other MAbs with positive reactivity showed patterns similar to those
described here and therefore they were not pursued further. Overall, most MAbs
reacted to multiple stages (Table 1; see Fig. S2 and S3 in the supplemental material),
suggesting that they recognize epitopes that are expressed broadly across the intracellular life cycle. We identiﬁed one antibody, 1E12, that recognized every life stage,
excluding oocysts (Table 1 and Fig. S2 and S3). Based on its reactivity pattern, 1E12
recognizes an epitope associated with the membrane of all life cycle stages (Fig. 2). Due
to its broad spectrum and membrane pattern of reactivity, 1E12 can be used to identify
speciﬁc stages based on appearance, size, and number of nuclei. For example, 1E12 can
be used to distinguished type I meronts, which have 4 nuclei but a single cytoplasmic
mass (Fig. 2B), from type II meronts, which have four nuclei but have separated into 4
distinct merozoites (Fig. 2D). MAb 1E12 also stains the surface of type I merozoites
(Fig. 2C), allowing mature type I meronts to be clearly distinguished from immature
May/June 2018 Volume 3 Issue 3 e00124-18
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FIG 2 MAb 1E12 recognizes the parasite membrane of all life cycle stages, as shown by the cartoons at
the top and bottom (courtesy of Laura Kyro, reproduced with permission). Infected HCT-8 cells were ﬁxed
and stained with MAb 1E12 (green), rabbit anti-RH (Cp [red]) to detect C. parvum, and Hoechst to detect
DNA. Samples from 4 h postinfection were used to image trophozoites (A) and immature (B) and mature
(C) type I meronts, 32 h postinfection for type II meronts (D), or 48 h postinfection for macrogamonts (E)
and microgamonts (F). Scale bars ⫽ 3 m.

type I meronts. MAb 1E12 also recognized the membrane of macrogamonts (Fig. 2E)
and one end of the small microgametocytes within the microgamont (Fig. 2F).
MAb 1E12 has great utility as a “pan-crypto” antibody; it can be used to easily assess
the ability of different cell culture platforms to support Cryptosporidium growth as it
recognized all the major stages, which are distinguishable by their surface morphology.
Other antibodies identiﬁed through the screen did not have this broad reactivity but

TABLE 1 Staining patterns of mouse monoclonal antibodies against C. parvum
Staining pattern fora:
Hybridoma
1B6
1F9
2A11
1A11
1B5
1A5
1A12
1D2
5E3
5F7
4D8
1E12

Isotype
IgG1
IgG1
IgG2a
IgG2b
IgG2b
IgG1
IgG2b
IgG1
IgG1
IgG2a
IgM
IgG1

Oocyst
Outer wall

Sporozoite

Trophozoite

Type I
meront

Type I
merozoite

Type II
meront

Macrogamont

Microgamont

Polarized
Polarized
Polarized
Central
Polarized
Polarized
Polarized
Polarized
Polarized
Polarized
Membrane

Ring
Membrane
Membrane
Ring
Membrane
Punctate
Membrane
Membrane
Punctate
Variable
Membrane

Punctate
Cytoplasmic
Cytoplasmic
Cytoplasmic
Polarized
Punctate
Cytoplasmic
Membrane
Punctate
Variable
Membrane

Cytoplasmic
Cytoplasmic
Cytoplasmic
Cytoplasmic
Polarized
Polarized
Cytoplasmic
Polarized
Polarized
Cytoplasmic
Membrane

Polarized
Polarized
Cytoplasmic
Polarized
Polarized
Punctate
Membrane

“V” shape
Membrane

Membrane

aStaining

patterns are based on reactivity to infected mIECs (Fig. S2 and 3) and infected HCT-8 cells (images in the main ﬁgures) and reactivity on sporozoites
(Fig. S4). The different levels of shading denote strength of reactivity, with dark gray corresponding to strong staining and light gray reﬂecting weaker, positive
staining. Blank table cells indicate no reactivity.
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FIG 3 MAb 1B6 antibody stains the outer oocyst wall. Oocysts were either left unbleached or were
bleached for 10 min in a 40% bleach solution and then were either left unexcysted or were excysted in
a 0.75% sodium taurocholate solution for 60 min at 37°C. Oocysts were then plated on coverslips coated
with poly-L-lysine. Samples were ﬁxed and stained with 1B6 (green) and rabbit anti-RH (Cp [red]) to
detect C. parvum. Arrows indicate sporozoites. Scale bars ⫽ 5 m.

rather identiﬁed speciﬁc life cycle stages in distinguishable patterns, making them
useful for understanding life cycle progression in different culture systems. These
antibodies are described in detail below.
MAb 1B6 recognizes the oocyst outer wall. Only one antibody from the hybridoma library was speciﬁc for a single stage; MAb 1B6 only recognized oocysts and did
not show any reactivity toward asexual (Fig. S2 and S3) or sexual (Table 1) stages. MAb
1B6 detected residual oocysts from the inoculum that were present in mIECs (Fig. S1).
MAb 1B6 stained the oocyst wall in a continuous pattern (Fig. 3), similar to Crypt-a-glo,
a commercial reagent that is an oocyst-speciﬁc monoclonal antibody (Waterborne, Inc.)
(25). MAb 1B6 equally recognized oocysts that were either left unstimulated or stimulated to excyst (Fig. 3), suggesting it recognizes an epitope on the outer wall of the
oocyst. MAb 1B6 preferentially stained bleached oocysts (Fig. 3), a process that removes
the outer veil (26). Based on this result, it is likely that bleach treatment removes the veil
and exposes the 1B6 epitope on the outer wall. Interestingly, 1B6 did not stain
macrogamonts (Table 1), unlike the previously described MAb, OW50, which also reacts
to an outer oocyst wall protein and stains wall-forming bodies in mature macrogamonts (27).
MAbs 1B5 and 1F9 have distinctive trophozoite-speciﬁc patterns. Although
many of the antibodies generated here react to multiple life cycle stages, they still
provide markers for deﬁning development due to the unique patterns of staining they
detect in speciﬁc stages. For example, MAbs 1B5 and 1F9 detect a distinctive “donutshaped” pattern in trophozoites during the initial stages of asexual development
(Fig. 4C and E). Although both MAbs have a circular staining pattern on trophozoites,
1B5 staining has a smooth, continuous appearance, while 1F9 is punctate, implying the
two antibodies recognize different epitopes. While 1F9 did not show reactivity by
Western blotting, 1B5 recognized a 230-kDa product in sporozoites (Fig. S1).
When images of trophozoites were acquired by laser scanning confocal microscopy
and the z-stacks were rendered in three dimensions (3D), the resulting images revealed
that the epitope recognized by 1B5 is mostly conﬁned to the base of the parasite,
where it contacts the host cell, while 1F9 staining begins at the base and extends up
the side of the vacuole or parasite membrane (Fig. 4D and F). Because these antibodies
have a polarized recognition pattern in sporozoites (see Fig. S5 in the supplemental
material), their targets likely relocalize following invasion to this interface during initial
trophozoite growth.
The host-parasite interface is where the host cytoskeleton is reorganized into an
actin-rich pedestal during intracellular development (28–30). When infected HCT-8 cells
May/June 2018 Volume 3 Issue 3 e00124-18
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FIG 4 Antibodies that recognize unique patterns in trophozoites. (A) Cartoon representing the trophozoite stage (courtesy of Laura Kyro, reproduced with permission). (B) Transmission electron micrograph
of trophozoite growing in mIEC 24 h postinfection. The actin-rich host cell cytoskeleton is denoted by
brackets. The membrane-rich feeder organelle is indicated by arrows. Scale bar ⫽ 500 nm. (C and D)
Pattern of staining with MAb 1B5 (green) and rabbit anti-RH (Cp [red]) to detect C. parvum. (E and F)
Pattern of staining for MAb 1F9 and rabbit-anti-RH (Cp [red]) to detect C. parvum. For panels C to F, HCT-8
cells were infected with oocysts and ﬁxed and stained 24 h postinfection. Panels C and E show single
z-slices acquired by laser scanning confocal microscopy, Panels D and F show the 3D rendering of a full
z-stack. Scale bars in panels C and E ⫽ 2 m; scale bars in panels D and F ⫽ 1 m.

were stained with ﬂuorescently labeled phalloidin to visualize this actin pedestal,
labeling with 1B5 and 1F9 revealed that both MAbs formed a ring around the nascent
pedestal in trophozoites (Fig. S4A). Examination of z-slices generated by laser scanning
confocal microscopy revealed that the ring formed by 1B5 is within the same plane as
the pedestal, whereas the 1F9-labeled ring is positioned above the pedestal (Fig. S4A).
As trophozoites develop into meronts, the epitopes recognized by 1B5 and 1F9 were
redistributed, leading to more diffuse labeling that was no longer conﬁned to the base
of the parasite (Table 1, Fig. S2, and Fig. S4B).
The host-parasite interface is also the site where the parasite elaborates a
membrane-rich feeder organelle (31) (Fig. 4A). The nature of this feeder organelle is
uncertain, although the genomes of C. parvum (32) and C. hominis (33) contain a large
number of transporters, and it has been speculated that this interface is responsible for
transport of nutrients from the host (34). Consistent with this, a C. parvum ATP-binding
cassette protein that shares features with transporters has previously been localized to
this interface (18). Attempts to localize the epitopes recognized by 1B5 or 1F9 using
immunoelectron microscopy were not successful; however, based on their localization
pattern in trophozoites by ﬂuorescence microscopy, it is possible that the targets
recognized by either MAb are involved in the reorganization of the host cytoskeleton
and the generation of the feeder organelle. Hence, these MAbs may facilitate future
investigation into these two developmental processes.
MAb 5E3 recognizes mature type I merozoites in a polarized manner. Moving
forward in the parasite life cycle, the parasite progresses through asexual development
to replicate mitotically and generate 8 mature merozoites within type I meronts
(Fig. 5A). Transmission electron microscopy reveals that the apical end of merozoites in
mature type I meronts is characterized by many small secretory vesicles corresponding
to micronemes and cross sections of rhoptries (Fig. 5B and C), similar to what is seen
in sporozoites (35). Four MAbs (1A5, 1A12, 5E3, and 5F7) recognized both type I and
type II merozoites in a distinctive polarized pattern reminiscent of this apical specialization (Table 1), and these MAbs, along with others, also stain the apical end of
sporozoites (Fig. S5). An example of this polarized staining pattern is shown for 5E3
staining of fully developed merozoites in mature type I meronts (Fig. 5E and F and
Fig. S3). MAb 5E3 was also able to recognize immature type I meronts, where the
epitope is fainter and distributed along the membrane (Table 1) from mature type I
May/June 2018 Volume 3 Issue 3 e00124-18
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FIG 5 MAb 5E3 recognizes the apical end of merozoites. (A and D) Cartoons representing the type I
meront and merozoite, respectively (courtesy of Laura Kyro, reproduced with permission). (B and C)
Transmission electron micrograph of a mature meront in HCT-8 cells 24 h postinfection. Brackets denote
micronemes at the apical end of the merozoite. Scale bars ⫽ 500 nm. (E and F) HCT-8 cells were infected
with oocysts, ﬁxed at 24 h postinfection, and stained with MAb 5E3 (green) and rabbit-anti-RH (Cp [red])
to detect C. parvum. (E and F) Side (E) and top (F) view images of 3D-rendered images from a z-stack
acquired by laser scanning confocal microscopy. Scale bars ⫽ 1 m.

meronts that contain 8 merozoites, which demonstrate strong polarized staining
(Fig. S3). Three-dimensional rendering of z-stacks acquired by laser scanning confocal
microscopy revealed that the epitope recognized by 5E3 is concentrated at one end of
the parasite (Fig. 5E and F). This polarized pattern is similar to that of a previously
published mouse monoclonal antibody, 4E9, which stains the apical end of sporozoites
and also recognizes trails of protein shed by the sporozoite during gliding motility (12).
Attempts to label the apical end of sporozoites directly with 5E3 by immunoelectron
microscopy were unsuccessful, but based on its recognition pattern by ﬂuorescence
microscopy, it is likely that MAb 5E3 and other antibodies that stain in a highly
polarized pattern (Table 1) recognize components of apical secretory organelles, which
are implicated in host cell attachment and invasion (36, 37).
Antibodies that distinguish type I from type II meronts. The life cycle of
Cryptosporidium proceeds through two rounds of merogony, the ﬁrst of which culminates in eight merozoites (type I), while the second terminates with four merozoites
(type II) (31). Because the type I merogony cycle also proceeds through a 4-nucleus
stage, it can be difﬁcult to distinguish these immature type I stages from mature type
II stages based on the number of nuclei alone. To identify antibodies that recognize
type II meronts, we established a method to reliably distinguish type II meronts, which
contain 4 nuclei within mature merozoites, from “early stage” or immature type I
meronts, which can also contain 4 nuclei. To distinguish between these stages, we
pulse-labeled parasites growing in HCT-8 cells using 5-ethynyl-2=-deoxyuridine (EdU),
which labels replicating DNA (9), and detected incorporation ﬂuorescently using click
labeling (see Materials and Methods). By adding EdU in speciﬁc intervals after infection,
we identiﬁed actively replicating stages that were further deﬁned by nuclear morphology and number. Type II meronts were most commonly detected from 30 to 32 h
postinfection. When EdU was added during this 2-h interval, type II meronts were
identiﬁed by the presence of 4 nuclei that lacked EdU positivity, as they were mature
and no longer replicating, whereas 4-nucleus type I meronts were EdU positive because
they were still actively replicating (Fig. 6).
Based on differential EdU labeling, we identiﬁed several antibodies that recognized
type II meronts with different staining patterns (Table 1). For example, MAb 1A5 did not
stain immature type 1 meronts (Fig. 6A) but did stain mature type I (Fig. 6B) and type
II (Fig. 6C) meronts. Because of this pattern of reactivity, MAb 1A5 can be used to
positively identify type II meronts from immature type I meronts, which also contain 4
May/June 2018 Volume 3 Issue 3 e00124-18

msphere.asm.org 7

Wilke et al.

Downloaded from http://msphere.asm.org/ on June 22, 2018 by guest

FIG 6 MAb 1A5 recognizes mature type I and type II meronts but not immature type I meronts. Cartoons representing the
type I and II meronts were created by Laura Kyro and are reproduced with permission. (A) Staining of immature type I meronts
deﬁned by four EdU-positive nuclei and lack of deﬁned merozoites by phase-contrast (Merge ⫹ Phase). (B) Staining of mature
type I meronts deﬁned by a lack of EdU staining and the presence of deﬁned merozoites by phase-contrast microscopy
(Merge ⫹ Phase). (C) Staining of type II meronts as deﬁned by four nuclei that lack EdU staining as well as the presence of
4 individual merozoites by phase-contrast microscopy (Merge ⫹ Phase). Infected HCT-8 cells were incubated with the
thymidine analog EdU for 2 h starting 30 h postinfection and then were ﬁxed and treated with an EdU Click-It 488 labeling
kit (green) and stained with MAb 1A5 (red) and Hoechst DNA stain (blue). Scale bars ⫽ 3 m.

nuclei. By Western blotting, 1A5 recognized a 125-kDa band (Fig. S1), and this protein
serves as a marker of mature merozoites, whether they are type I or II.
Despite their superﬁcial similarity, merozoites produced by these two rounds of
merogony have different fates. Type I merozoites are thought to reinitiate multiple
rounds of asexual replication, while type II merozoites are thought to give rise to
gamonts (10). Unfortunately, we did not identify any MAbs that only stain type II
meronts, nor have such reagents been described previously, although differences have
been detected by ultrastructure (31). Consequently, the ability to track type II meronts
using MAbs like 1A5 combined with EdU staining provides a convenient means of
monitoring development of stages that are committed to undergo sexual development.
Antibodies that distinguish sexual stage development. Merozoites released by
type II meronts are thought to give rise to micro- and macrogamonts, which eventually
undergo fertilization to form oocysts, although this last step does not occur efﬁciently
in vitro. The majority of MAbs studied here did not recognize sexual stages, with two
exceptions (Table 1). For example, MAbs 1A5 and 1B5 broadly stain asexual stages but
fail to stain either micro- or macrogamonts (Table 1). The membrane-reactive MAb 1E12
did stain the membranes of both microgamonts and macrogamonts (Fig. 2 and
Table 1), although the staining of macrogamonts did not provide a unique recognition
pattern that differentiated it from asexual stages such as meronts. In contrast, MAb 4D8
showed a characteristic “V” (Fig. 7C) or line pattern (Fig. 7D) in macrogamonts (Table 1),
a reactivity pattern not reported in any published studies with other Cryptosporidium
antibodies. When examined by transmission electron microscopy, macrogamonts were
found to contain a prominent striated ﬁber running through the center of the cytoplasm (Fig. 7B). This striated ﬁber is not seen in all thin sections, possibly explaining why
some electron microscopy studies of in vivo infection do not mention the ﬁber at all
(31), and only one published study contains an image of a macrogamont with a ﬁber,
although it is not described in detail (38). Attempts to label the ﬁber directly with 4D8
by immunoelectron microscopy were not successful, so while we cannot deﬁnitively say
4D8 recognizes this structure, it seems highly likely based on its appearance. The
May/June 2018 Volume 3 Issue 3 e00124-18
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FIG 7 Antibodies with reactivity to C. parvum sexual stages. (A and E) Cartoons representing the macrogamont and
microgamont, respectively (courtesy of Laura Kyro, reproduced with permission). (B) Transmission electron micrograph of the macrogamont within an HCT-8 cell 48 h postinfection. Scale bar ⫽ 500 nm. (C and D) Infected HCT-8
cells were ﬁxed and stained 72 h postinfection with rabbit-anti-RH (Cp [red]) to detect C. parvum and MAb 4D8
(green). Scale bars ⫽ 3 m. (F) Transmission electron micrograph of the microgamont within an HCT-8 cell 48 h
postinfection. Scale bar ⫽ 500 nm. (G) Infected HCT-8 cells were ﬁxed and stained 72 h postinfection with an
anti-phosphohistone H3 (Ser10) antibody (green). Scale bar ⫽ 3 m. (H) Infected HCT-8 cells were incubated with
the thymidine analog EdU for 2 h starting 46 h postinfection before ﬁxation. Cells were treated with an EdU Click-It
488 labeling kit (green) to detect microgametocyte nuclei undergoing replication (arrows) and stained with
rabbit-anti-RH (Cp [red]) to detect C. parvum. Scale bar ⫽ 3 m.

molecular nature of this striated ﬁber is also uncertain, as the streamlined genome of
C. parvum contains homologs for tubulin, actin, and several actin-related proteins
(http://cryptoDB.org). The genome also contains orthologues of articulins, which are
known in other apicomplexans as inner membrane complex proteins (IMCs) (39),
although they are not annotated as such in C. parvum (http://cryptoDB.org). The
striated ﬁber observed in macrogamonts does not resemble microtubules that are
typically found apically or the meshwork of IMC proteins that are localized under the
membrane of motile stages (39). Hence, this striated ﬁber may represent a novel
assemblage of actin ﬁlaments, or a novel cytoskeletal element that imparts some form
of structural integrity within macrogamonts. Currently, macrogamonts are recognized
by their size and diffuse nucleus. In contrast, the staining pattern of 4D8 provides a
deﬁnitive marker for this stage based on the strongly striated pattern, while it stains
other stages much more diffusely (Fig. S3).
We did not identify any antibodies that speciﬁcally stain microgamonts, although
they are recognizable by their many small nuclei, which number 16 in mature microgamonts (Fig. 7). These small, replicating nuclei were easily visualized using a commercially available anti-phosphohistone H3 antibody (Fig. 7G), which stains DNA during
mitosis (40), or through the incorporation of EdU during DNA replication (Fig. 7H).
Conclusions. Previous studies on the development of C. parvum in vitro have been
hampered both by the lack of an efﬁcient in vitro system for propagation and by the
lack of speciﬁc reagents to stage development. We have taken advantage of developments in stem cell biology to propagate C. parvum in mouse IECs, which more closely
resemble the intestinal cells that support growth in vivo compared to adenocarcinoma
cell lines. Although attempts to achieve complete development of C. parvum in mIECs
are ongoing, here we have used this system to generate antigens for production of
novel MAbs to intracellular stages. This approach has been effective at generating
reagents that deﬁne stage-speciﬁc patterns of expression, which greatly enhances our
ability to deﬁne speciﬁc stages during in vitro growth. Collectively these reagents
May/June 2018 Volume 3 Issue 3 e00124-18
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should be useful for future studies to (i) deﬁne developmental progression during
in vitro culture, (ii) identify conditions necessary to support complete development
in vitro, and (iii) pinpoint the stages that are susceptible to chemotherapy, thereby
supporting efforts at target identiﬁcation.
MATERIALS AND METHODS
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Ethics statement. Animal studies were conducted according to the Public Health Service Policy on
Humane Care and Use of Laboratory Animals (Ofﬁce of Laboratory Animal Welfare, National Institutes of
Health, Bethesda, MD). Animals were maintained in Association for Assessment and Accreditation of
Laboratory Animal Care-approved facilities. Animal studies were approved by the Institutional Animal
Studies Committee at the School of Medicine, Washington University in St. Louis.
Adenocarcinoma cell culture. Human ileocecal adenocarcinoma cells (HCT-8; ATCC CCL-244) were
maintained in RPMI 1640 medium (Gibco, ATCC modiﬁcation) supplemented with 10% fetal bovine
serum (FBS). Human colorectal adenocarcinoma cells (Caco-2; ATCC HTB-37) were maintained in minimum essential medium (Corning CellGro) supplemented with 20% FBS. Cell lines were tested for the
presence of mycoplasma and conﬁrmed negative with the e-Myco plus Mycoplasma PCR detection kit
(Boca Scientiﬁc).
3D spheroid cell culture. Primary ileal epithelial stem cells isolated from 8- to 10-week-old C57BL/6
mice were obtained from the laboratory of Thad Stappenbeck, Washington University in St. Louis. Ileal
stem cells were expanded and maintained as 3D spheroid cultures in Matrigel (BD Biosciences), as
described previously (41). Spheroid cultures were grown in 50% L-WRN cell-derived conditioned medium
(CM) containing 10 M Y-27632 (ROCK inhibitor; Tocris Bioscience). The medium was changed every
2 days, and the cells were passaged every 3 days in a 1:6 split.
Formation of Transwell monolayers. To form monolayers, spheroids from 3-day-old stem cell
cultures were recovered from Matrigel and dissociated with trypsin as described previously (24).
Transwells (polyester membrane, 0.4-m pore; Corning Costar) were prepared for cell seeding by coating
the upper compartment with 100 l of a 1:40 dilution of Matrigel for 20 min at 37°C. Excess Matrigel was
aspirated off the membrane, and approximately 2 ⫻ 105 cells, diluted in 100 l CM with 10 M Y-27632,
were seeded onto the coated membrane. Medium (700 l of CM with Y-27632) was added to the bottom
compartment of the Transwell. About 24 h after seeding, the medium in the top and bottom compartments of the Transwell was changed to 0% CM, referred to as “primary medium” (consisting of advanced
Dulbecco’s modiﬁed Eagle’s medium [DMEM]–Ham’s F-12 containing 20% fetal bovine serum, 100 U of
penicillin, 0.1 mg/ml streptomycin, and 2 mM L-glutamine [Sigma]). Monolayers were infected with
oocysts 24 h after seeding.
Oocyst preparation and excystation. Oocysts were provided by the Kuhlenschmidt lab (University
of Illinois at Urbana Champaign). The AUCP-1 isolate of C. parvum was maintained in male Holstein
calves, and oocysts were puriﬁed as described previously (42). Oocysts were stored at 4°C in 50 mM
Tris–10 mM EDTA (pH 7.2). Before infection, 1 ⫻ 108 puriﬁed oocysts were diluted into 1 ml of Dulbecco’s
phosphate-buffered saline (DPBS; Corning Cellgro) and treated with 1 ml of 40% bleach (commercial
laundry bleach containing 8.25% sodium hypochlorite) for 10 min on ice. Oocysts were then washed 4
times in DPBS containing 1% (wt/vol) bovine serum albumin (BSA; Sigma) and resuspended in 1 ml DPBS
with 1% BSA. For some experiments, oocysts were excysted prior to infection by incubating the oocysts
with 0.75% (wt/vol) sodium taurocholate (Sigma) at 37°C for 60 min. Excysted oocysts were washed
once with cell medium prior to being added to cells.
For sporozoite and oocyst labeling experiments, coverslips were coated with poly-L-lysine (PLL;
Sigma) overnight at room temperature. After aspirating the PLL and allowing the coverslips to dry,
unexcysted oocysts or a mixture of excysted oocysts and sporozoites were added to the coverslips and
allowed to settle for 20 min. Unbleached oocysts were washed three times with sterile DPBS before being
plated onto coverslips. The oocysts or sporozoites were ﬁxed in 4% formaldehyde, permeabilized with
0.05% saponin (except where stated), and stained.
Growth of C. parvum in Transwell mIEC monolayers. At 24 h after plating, mIECs were infected
with 2 ⫻ 106 oocysts diluted in primary medium added to the top compartment of the Transwell. The
medium was changed in the top and bottom compartments of the Transwell daily during infection. To
measure C. parvum growth in infected monolayers, the medium in the top compartment was removed,
and 50 l of buffer (5 mM Tris-HCl [pH 8.5]) containing 50 g/ml proteinase K (Sigma) was added. Cells
were scraped into the lysis buffer using a pipette tip, and the lysate was transferred to a PCR tube and
incubated at 37°C for 60 min, 56°C for 60 min, and 95°C for 10 min. Two microliters of the lysate was used
as a template in the quantitative PCRs (qPCRs) with SYBR green PCR master mix (Applied Biosystems).
Reactions were performed on a Stratagene MX3000P quantitative reverse transcription-PCR (qRT-PCR)
system with the following ampliﬁcation conditions: initial denaturation at 95°C for 10 min and 45 cycles
of denaturation at 95°C for 5 s, annealing at 55°C for 10 s, and extension at 72°C for 30 s. The sequences
of the primers targeting C. parvum GAPDH (glyceraldehyde-3-phosphate dehydrogenase) are as follows:
forward primer 5= AAGGACTGGAGAGCAGGAAG 3= and reverse primer 5= AAAGCTGGGATGACCTTACC 3=.
A standard curve for C. parvum genomic DNA was generated by lysing a known number of oocysts and
creating a dilution series.
Antigen preparation. About 48 h postinfection, medium in the top compartment of the infected
Transwells was removed. Groups of 10 Transwells were lysed in 100 l of NP-40 lysis buffer (150 mM
sodium chloride, 1% NP-40, 50 mM Tris [pH 8.0]) with protease inhibitor cocktail (Roche Diagnostics). The
protein concentration of the lysate was checked by bicinchoninic acid (BCA) assay (Thermo Scientiﬁc),
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adjusted to 1 mg/ml, and stored at ⫺20°C. Antigen was emulsiﬁed with TiterMax classic adjuvant (Sigma)
in a 1:1 ratio prior to injection into mice.
Mouse immunization. Five 8- to 10-week-old female inbred BALB/c mice (Charles River Laboratories,
Inc.) were immunized with 6 injections of antigen over 2 weeks. Mice were injected in the same footpad
every 3 or 4 days. The ﬁrst two injections consisted of a 1:1 emulsion of antigen and adjuvant, and the
remaining 4 injections consisted of antigen only. Each injection was 20 l in volume: when using
antigen-adjuvant mixture, the mice received 10 g of antigen, and when using antigen alone, the mice
received 20 g of antigen. Seventeen days after the initial injection, the mice were sacriﬁced and the
popliteal lymph nodes draining the injected footpads were isolated and kept in serum-free medium on
ice until fusion.
Hybridoma fusion and screening. The popliteal lymph node cells were fused with myeloma cells
(P3X63Ag8.653) at a 5:1 ratio with polyethylene glycol 1500 (PEG 1500; Sigma-Aldrich) following standard
procedures by the Washington University Hybridoma Center (43). Supernatants were harvested for
screening when the cells were 50% conﬂuent (about 2 weeks after fusion). Hybridomas were screened
for reactivity against C. parvum grown in Caco-2 cells plated on 96-well plates (Greiner Bio-One).
Monolayers cells were permeabilized with 0.05% saponin (Sigma) and blocked with a solution containing
0.05% saponin, 5% normal goat serum, and 5% FBS. Hybridoma supernatants were added to the wells
in addition to a solution containing anti-RH antibody (rabbit polyclonal sera raised against Toxoplasma
gondii strain RH; Covance WU 1047) at a 1:1,000 dilution and 0.02% saponin. After a 1-h incubation, cells
were washed and then stained with secondary antibodies conjugated to Alexa Fluor dyes (Thermo
Fisher) diluted in 0.01% saponin solution. Positive hybridomas were expanded in Iscoves’ medium
(Sigma) supplemented with 20% FBS, cryopreserved in culture medium supplemented with 10%
dimethyl sulfoxide (DMSO), and stored in liquid nitrogen.
Hybridoma subcloning and expansion. Positive hybridomas were taken through two rounds of
subcloning by single-cell limiting dilution to ensure clonality. At each stage, the hybridoma suicide
supernatants (collected when overgrowth of cells results in a decrease in viability to 20%) were screened
for reactivity. Hybridomas were weaned in a stepwise manner into 10% FBS before being transferred into
a CELLine ﬂask (Wheaton) for concentrated monoclonal antibody production. The isotype identiﬁcation
for the hybridomas was done with the Pierce Rapid isotyping kit (Thermo Fisher). Some of the hybridoma
isotyping results were conﬁrmed with the Hybridoma Core at Washington University or the Rapid mouse
immunoglobulin isotyping kit (Antagen).
Immunoﬂuorescence analysis of C. parvum in mIECs. mIECs grown on Transwells were infected
with 1 ⫻ 106 oocysts 24 h after plating. After 4 h, monolayers were washed with DPBS and the medium
in the top Transwell compartment was replaced. Monolayers were ﬁxed 24 h postinfection, permeabilized, and blocked as described above. Both primary antibodies (hybridoma supernatants listed in Table 1)
and secondary antibodies (anti-IgG or anti-IgM) conjugated to Alexa Fluor dyes (Thermo Fisher) were
diluted in 0.01% saponin solution for staining. Samples were stained with Hoechst (Thermo Fisher), and
the membrane was cut out from the Transwell insert and mounted with Prolong Diamond antifade
mountant (Thermo Fisher). Imaging was done on a Zeiss Axioskop Mot Plus ﬂuorescence microscope
equipped with a 100⫻, 1.4 NA Zeiss Plan Apochromat oil objective and an AxioCam MRm monochrome
digital camera. Exposure times for each antibody were established based on optimal autoexposure times
for the most intensely staining stages and then maintained consistently for all stages for a given
antibody. Images were acquired using AxioVision software (Carl Zeiss, Inc.).
Immunoﬂuorescence analysis of C. parvum in HCT-8 cells. HCT-8 cells grown on coverslips were
infected 24 h postseeding with 1 ⫻ 106 oocysts per well and ﬁxed at 24 h postinfection for asexual stages
or 48 to 72 h postinfection for sexual stages and then stained for immunoﬂuorescent antibody (IFA) as
described above. To identify type II meronts, cells were infected with 1 ⫻ 106 excysted oocysts per well
and then incubated with 10 M EdU for 2 h starting 30 h postinfection before ﬁxation and permeabilized
as described above. Cells were then treated with the Click-iT Plus EdU Alexa Fluor 488 imaging kit
(Thermo Fisher) for 30 min and then stained with mouse monoclonal antibodies and rabbit anti-RH to
detect C. parvum, followed by secondary antibodies conjugated to Alexa Fluor dyes (Thermo Fisher). Cells
were stained with Hoechst and mounted as described previously. To detect individual microgametocyte
nuclei, infected HCT-8 cells were either stained with anti-phosphohistone H3 (Cell Signaling Technology;
1:200) or treated with 10 M EdU for 2 h starting 46 h postinfection before ﬁxing and staining as
described above. To detect host actin, infected HCT-8 cells were ﬁxed and permeabilized as described
above and then incubated with Alexa Fluor 488-phalloidin (Thermo Fisher) for 20 min before proceeding
with antibody staining, as described above. Epiﬂuorescent images were acquired as described for the
mIECs. For confocal images, infected monolayers were prepared as described and then viewed with a
Zeiss LSM880 laser scanning confocal microscope (Carl Zeiss, Inc.) equipped with a 63⫻, 1.4 NA Zeiss Plan
Apochromat oil objective and a GaAsP detector. ZEN 2.1 Black Edition software was used to obtain
z-stacks through the entire height of the parasites with confocal z-slices of 0.230 m. Three-dimensional
images were generated using the visualization module of Volocity version 6.3 (Improvision).
Western blot analysis. Oocysts and sporozoites were lysed in 1% NP-40 lysis buffer containing
protease inhibitor cocktail (Roche Diagnostics). Oocysts were bleached prior to lysis. Sporozoites were
prepared from excysted oocysts that were ﬁltered through a 1-m-pore ﬁlter (Whatman) to remove
unexcysted oocysts and excysted oocyst shells. Samples were lysed on ice for 30 min with occasional
vortexing and then centrifuged at 14,000 for 3 min; the supernatant was moved to a new tube and frozen
at ⫺20°C. Prior to use, lysates were thawed and reduced using dithiothreitol (DTT) at a ﬁnal concentration of 100 mM. Samples were resolved on a 10% SDS-PAGE gel and then transferred to a nitrocellulose
membrane, blocked with the Odyssey blocking buffer (LI-COR). Anti-RH antibody was used at a
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concentration of 1:500. A secondary goat anti-mouse IR dye 800CW (LI-COR) was used at a concentration
of 1:10,000. Samples were imaged with a LI-COR Odyssey imaging system.
For detection with monoclonal antibodies, sporozoite samples obtained after oocyst excystation
were lysed in sample buffer and boiled for 5 min at 95°C. They were then centrifuged at 14,000 ⫻ g for
1 min, and the supernatant was used for loading. Samples were resolved on a 10% SDS-PAGE gel,
transferred to a nitrocellulose membrane, and blocked with 5% BSA. Monoclonal antibodies against
C. parvum were used at 1:250, and secondary goat anti-mouse antibody conjugated to horseradish
peroxidase (HRP) was used at 1:10,000. Signal detection was done using the Amersham ECL Prime
Western kit (GE Healthcare). Among the antibodies highlighted here, we were only able to detect reliable
signals in sporozoites for two of them (i.e., 1B5 and 1A5).
Transmission electron microscopy. For ultrastructural analyses, infected mIECs on Transwell membranes or trypsinized HCT-8 monolayers were ﬁxed in a freshly prepared mixture of 1% glutaraldehyde
and 1% osmium tetroxide (both from Polysciences, Inc.) in 50 mM phosphate buffer at 4°C for 30 min.
Samples were then rinsed multiple times in cold distilled water (dH2O) prior to en bloc staining with 1%
aqueous uranyl acetate (Ted Pella, Inc.) at 4°C for 3 h. Transwell membranes were removed from the
insert using a scalpel. Following several rinses in dH2O, samples were dehydrated in a graded series of
ethanol and embedded in Eponate 12 resin (Ted Pella, Inc.). Sections of 95 nm were cut with a Leica
Ultracut UCT ultramicrotome (Leica Microsystems, Inc.), stained with uranyl acetate and lead citrate, and
viewed on a JEOL 1200 EX transmission electron microscope (JEOL United States, Inc.) equipped with an
AMT 8 megapixel digital camera and AMT Image Capture Engine V602 software (Advanced Microscopy
Techniques).
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